Drug Shortage Report for TEVA-FLUOXETINE
Report ID | 155162 |
Drug Identification Number | 02216582 |
Brand name | TEVA-FLUOXETINE |
Common or Proper name | TEVA-FLUOXETINE 10MG CAPS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | FLUOXETINE |
Strength(s) | 10MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-02-15 |
Estimated end date | 2022-03-31 |
Actual end date | 2022-02-16 |
Shortage status | Resolved |
Updated date | 2022-02-17 |
Company comments | Duplicate Record - created in error do not use. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-02-17 | French | Compare |
v3 | 2022-02-17 | English | Compare |
v2 | 2022-02-17 | French | Compare |
v1 | 2022-02-17 | English | Compare |
Showing 1 to 4 of 4